2026-10-14T09:49:42Z https://api.figshare.com/v2/oai

oai:figshare.com:article/34026975 2026-09-29T17:39:11Z category_46 category_64 category_132 category_134 portal_5 item_type_3 month_year_09_2026

<p>Raw data corresponding to main manuscript figures.</p> Declan D. Pigeaud (22002457) Viktoriya Borisevich (546564) Jacquelyn Turcinovic (12047448) Krystle N. Agans (9239742) Daniel J. Deer (9239745) Mack B. Harrison (17718407) Rachel O’Toole (22954878) Natalie S. Dobias (9254952) Abhishek N. Prasad (9239736) Karla A. Fenton (9188846) Robert W. Cross (9239733) Thomas W. Geisbert (9239748) Immunology Cancer Infectious Diseases Virology rvsv &# 8710 resource environments challenging protein subunit form protective response driven overall mortality rate larger case burden highly pathogenic paramyxoviruses demonstrated ideal characteristics vectored vaccine displaying human vaccine development often fatal disease experimental vaccines displaying achieve equivalent protection canarypox vectors failed lethal hev challenge g vaccine cross experimental vaccine durable protection b challenge zoonotic spillover utilize mrna uniformly cross surface glycoproteins southeast asia produce severe previously developed present work preclinical models nonhuman primates less transmissible largely focused immunogen selection hev disease hendra virus b ). 75 %, 57 %. <p>Raw data corresponding to main manuscript figures.</p> 2026-09-22T17:39:09Z Dataset Dataset 10.1371/journal.ppat.1014646.s006 https://figshare.com/articles/dataset/_p_Raw_data_corresponding_to_main_manuscript_figures_p_/34026975 CC BY 4.0